Translational Research
Volume 154, Issue 1 , Pages 40-48 , July 2009

Patterns of Nogo-A, NgR, and RhoA expression in the brain tissues of rats with focal cerebral infarction

Received 16 January 2009 ,Revised 10 April 2009 ,Accepted 14 April 2009.

References 

  1. Pei Z, Pang SF, Cheung RT. Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model. Stroke. 2003;34:770–775
  2. Eslamboli A, Grundy RI, Irving EA. Time-dependent increase in Nogo-A expression after focal cerebral ischemia in marmoset monkeys. Neurosci Lett. 2006;408:89–93
  3. Weinmann O, Schnell L, Ghosh A, et al. Intrathecally infused antibodies against Nogo-A penetrate the CNS and downregulate the endogenous neurite growth inhibitor Nogo-A. Mol Cell Neurosci. 2006;32:161–173
  4. Papadopoulos CM, Tsai SY, Alsbiei T, et al. Functional recovery and neuroanatomical plasticity following middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat. Ann Neurol. 2002;51:433–441
  5. Wanga H, Yaoa Y, Jiang X, Chena D, Xiong Y, Mu D. Expression of Nogo-A and NgR in the developing rat brain after hypoxia–ischemia. Brain Res. 2006;1114:212–220
  6. He Z, Koprivica V. The Nogo signaling pathway for regeneration block. Annu Rev Neurosci. 2004;27:341–368
  7. Woolf CJ, Bloechlinger S. Neuroscience. It takes more than two to Nogo. Science. 2002;297:1132–1134
  8. Wong ST, Henley JR, Kanning KC, Huang KH, Bothwell M, Poo MM. A P75 (NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat Neurosci. 2002;5:1302–1308
  9. Shao Z, Browning JL, Lee X, et al. TAJ/TRPY, an orphan TNF receptor family member, binds nogo-66 receptor 1 and regulates axonal regeneration. Neuron. 2005;45:353–359
  10. Al Halabiah H, Delezoide AL, Cardona A, Moalic JM, Simonneau M. Expression pattern of NOGO and NgR genes during human development. Gene Expr Patt. 2005;5:561–568
  11. Chen MS, Huber AB, van der Haar ME, et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature. 2000;403:434–439
  12. Taketomi M, Kinoshita N, Kimura K, et al. Nogo-A expression in mature oligodendrocytes of rat spinal cord in association with specific molecules. Neurosci Lett. 2002;332:37–40
  13. Huber AB, Weinmann O, Brosamle C, Oertle T, Schwab ME. Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J Neurosci. 2002;22:3553–3567
  14. Wang X, Chun SJ, Treloar H, Vartanian T, Greer CA, Strittmatter SM. Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon–myelin and synaptic contact. J Neurosci. 2002;22:5505–5515
  15. Park SW, Kim YB, Hwang SN, et al. The effects of N-methyl-N-nitrosourea and azoxymethane on focal cerebral infarction and the expression of p53, p21 proteins. Brain Res. 2000;855:298–306
  16. Jiang KW, Zhang Y, Shui QX. Possible mechanism of electroacupuncture preconditioning for hypoxia/ischemic brain injury protection effect in neonatal rats. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2003;23(12):914–917
  17. Prinjha R, Moore SE, Vinson M, et al. Inhibitor of neurite outgrowth in humans. Nature. 2000;403:383–384
  18. Domeniconi M, Cao Z, Spencer T, et al. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron. 2002;35:283–290
  19. Oertle T, Schwab ME. Nogo and its paRTNers. Trends Cell Biol. 2003;13:187–194
  20. O'Neill P, Whalley K, Ferretti P. Nogo and Nogo-66 receptor in human and chick: implications for development and regeneration. Dev Dyn. 2004;231:109–121
  21. Buss A, Sellhaus B, Wolmsley A, Noth J, Schwab ME, Brook GA. Expression pattern of NOGO-A protein in the human nervous system. Acta Neuropathol. 2005;110:113–119
  22. Bandtlow CE. Regeneration in the central nervous system. Exp Gerontol. 2003;38:79–86
  23. Seymour AB, Andrews EM, Tsai SY, et al. Delayed treatment with monoclonal antibody IN-1 1 week after stroke results in recovery of function and corticorubral plasticity in adult rats. J Cereb Blood Flow Metab. 2005;25:1366–1375
  24. Wang KC, Koprivica V, Kim JA, et al. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature. 2002;417:941–944
  25. Wang F, Liang Z, Hou Q, et al. Nogo-A is involved in secondary axonal degeneration of thalamus in hypertensive rats with focal cortical infarction. Neurosci Lett. 2007;417:255–260
  26. Marklund N, Fulp CT, Shimizu S, et al. McIntosh. Selective temporal and regional alterations of Nogo-A and small proline-rich repeat protein 1A (SPRR1A) but not Nogo-66 receptor (NgR) occur following traumatic brain injury in the rat. Exp Neurol. 2006;197:70–83
  27. Niedero B, Oertle T, Fritsche J, et al. Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. J Neurosci. 2002;22:10368–10376
  28. Wiessner C, Bareyre FM, Allegrini PR, et al. Anti-Nogo-A antibody infusion 24 hours after experimental stroke improved behavioral outcome and corticospinal plasticity in normotensive and spontaneously hypertensive rats. J Cereb Blood Flow Metab. 2003;23:154–165
  29. Cheatwood JL, Emerick AJ, Schwab ME, Kartje GL. Nogo-A expression after focal ischemic stroke in the adult rat. Stroke. 2008;39:2091–2098
  30. Zhou C, Li Y, Nanda A, Zhang JH. HBO suppresses Nogo-A, NgR, or RhoA expression in the cerebral cortex after global ischemia. Biochem Biophys Res Commun. 2003;309:368–376
  31. Brabeck C, Mittelbronn M, Bekure K, et al. Effect of focal cerebral infarctions on lesional RhoA and RhoB expression. Arch Neurol. 2003;60:1245–1249

PII: S1931-5244(09)00147-9

doi: 10.1016/j.trsl.2009.04.005

Translational Research
Volume 154, Issue 1 , Pages 40-48 , July 2009

Article Tools

* Image Usage & Resolution